The world of hepatitis research is small, still no publication covers hepatitis research and drug development as comprehensively as Hepatitis Weekly.
Not only does Hepatitis Weekly bring you more reports, but more coverage of every aspect of hepatitis research, from drug candidate identification through launch and beyond.
Published weekly, each issue of Hepatitis Weekly has more than 35 articles that cover hepatitis diseases and research A-Z, including Hepatitis A, B, and C viruses, hepatitis vaccines, disease associations such as HIV-coinfection and other autoimmune diseases, liver cancer and transplantation, steatosis, cirrhosis, epidemiology, as well as the associated work being done in genomics, genetics and molecular biology.
But important hepatitis research news is only half the picture. Hepatitis Weekly also provides key business intelligence regarding marketing, distribution, licensing, regulatory actions, personnel and funding for the pharmaceutical and biotech companies involved in hepatitis research and drug manufacturing.
NewsRx editors collect coverage from more than 4,000 peer-reviewed journals, dozens of industry meetings, medical news wires, pharmaceutical and biotech company internet sites, purchased databases, and press releases.
Each article, usually no more than 500 words, is written to be an information-heavy, concise report of the pertinent facts, together with full references and citations for original source material. You get a fast, user-friendly read that keeps you on top of all the important hepatitis research-related developments for that week.
Hepatitis Weekly is available in print or online at www.NewsRx.com. Email versions can be delivered directly to your desktop. Site licenses are also available for corporate use.
Combination print and email subscriptions are available, and all subscriptions come with online access to Hepatitis Weekly's archives, which go back to 1995. See a sample issue here.
Hepatitis Weekly was the first and only weekly newsletter dedicated to just hepatitis, and it quickly became the leading hepatitis research newsletter. We stake our 20-plus year history as a publisher that it remains the best.
But don't take our word for it. Sign up for our six-week, no-risk free trial and see for yourself. Receive six issues of Hepatitis Weekly, more than 200 articles, and see why it will become your indispensable tool for tracking hepatitis research news and developments.
Subscribe now and we'll give you $300 off our regular subscription price. You get the power of the most comprehensive hepatitis research coverage in the industry at a great discount.
Start today, and eliminate all those hours you normally spend scanning dozens of periodicals, websites, and other information sources. We've done it for you; we've got you covered.
|
2009
